MTMR6激活PI3K/AKT/mTOR信号通路促进肝癌细胞侵袭

梁霄; 陈虹宇; 彭雪琴

doi:10.16016/j.2097-0927.202304051

您当前的位置：

首页 >

文章列表页 >

MTMR6激活PI3K/AKT/mTOR信号通路促进肝癌细胞侵袭

基础医学 | 更新时间：2026-01-09

- MTMR6激活PI3K/AKT/mTOR信号通路促进肝癌细胞侵袭
- Myotubularin-related protein 6 promotes invasion of hepatocellular carcinoma cells by activating the PI3K/AKT/mTOR signaling pathway
- 陆军军医大学学报 2024年46卷第3期页码：249-256
- 作者机构：
  
  1.401331 重庆，重庆医科大学附属大学城医院全科医疗科
  2.401331 重庆，重庆医科大学附属大学城医院消化内科
- 作者简介：
  
  [彭雪琴, E-mail: 271354879@qq.com PENG Xueqin, E-mail: 271354879@qq.com
- 基金信息：
- DOI：10.16016/j.2097-0927.202304051
  中图分类号： R394.3;R730.23;R735.7
- 收稿：2023-04-12，
  
  修回：2023-09-19，
  
  纸质出版：2024-02-15
- 稿件说明：
移动端阅览
梁霄, 陈虹宇, 彭雪琴. MTMR6激活PI3K/AKT/mTOR信号通路促进肝癌细胞侵袭[J]. 陆军军医大学学报, 2024,46(3):249-256.

Xiao LIANG, Hongyu CHEN, Xueqin PENG. Myotubularin-related protein 6 promotes invasion of hepatocellular carcinoma cells by activating the PI3K/AKT/mTOR signaling pathway[J]. Journal of Army Medical University, 2024, 46(3): 249-256.
梁霄, 陈虹宇, 彭雪琴. MTMR6激活PI3K/AKT/mTOR信号通路促进肝癌细胞侵袭[J]. 陆军军医大学学报, 2024,46(3):249-256. DOI： 10.16016/j.2097-0927.202304051.

Xiao LIANG, Hongyu CHEN, Xueqin PENG. Myotubularin-related protein 6 promotes invasion of hepatocellular carcinoma cells by activating the PI3K/AKT/mTOR signaling pathway[J]. Journal of Army Medical University, 2024, 46(3): 249-256. DOI： 10.16016/j.2097-0927.202304051.

摘要

目的

探究肌微管素相关蛋白6(myotubularin-related protein 6

MTMR6)对人肝癌细胞(HepG2)侵袭能力的影响及潜在的分子机制。

方法

在GEO数据库中通过分析肝癌组织与非癌肝组织的测序结果，筛选出差异表达基因MTMR6，随后从癌症基因组图谱(TCGA)数据库中对MTMR6与通路相关性评分进行Spearman分析，最后通过Genemania数据库分析MTMR6与信号通路蛋白的互作关系。比较MTMR6在人正常肝细胞系(LO-2)和肝癌细胞系(Huh-7和HepG2)中的蛋白表达情况；选取HepG2作为研究对象，沉默或过表达MTMR6基因，运用Transwell实验检测细胞侵袭能力，蛋白免疫印迹实验(Western blot)检测MTMR6、PI3K、p-PI3K、AKT、p-AKT、mTOR、p-mTOR、MMP-2和MMP-9蛋白表达。

结果

MTMR6基因在肝癌组织中的表达明显高于癌旁组织，并且MTMR6与PI3K/AKT/mTOR信号通路呈正线性相关(

＜0.01)，MTMR6与PI3K、AKT、mTOR蛋白之间存在互作关系。与LO-2和Huh-7细胞相比，MTMR6在HepG2细胞中的表达水平明显升高(

＜0.01)。将HepG2细胞中MTMR6基因过表达，细胞侵袭能力明显增强(

＜0.01)，而将HepG2细胞中MTMR6基因沉默，细胞侵袭能力明显下降(

＜0.01)。沉默MTMR6基因导致PI3K、AKT、mTOR蛋白的磷酸化水平以及MMP-2和MMP-9表达水平下降(

＜0.01)，而过表达MTMR6则促进PI3K、AKT、mTOR蛋白的磷酸化水平以及MMP-2和MMP-9表达水平升高(

＜0.01)。使用特异性PI3K抑制剂LY294002阻断PI3K/AKT/mTOR通路下调MMP-2、MMP-9表达(

＜0.01)，但对MTMR6表达无影响。

结论

MTMR6通过激活PI3K/AKT/mTOR信号通路促进肝癌细胞发生侵袭。

Abstract

Objective

To explore the effect of myotubularin-related protein 6 (MTMR6) on the invasion of hepatocellular carcinoma cell line HepG2 and the potential molecular mechanism.

Methods

By analyzing the sequencing results of liver cancer tissues and adjacent tissues in Gene Expression Omnibus (GEO) database

MTMR6 gene was screened out

and Spearman analysis was used to analyze the correlation of MTMR6 and pathway in the Cancer Genome Atlas (TCGA) database. Finally

the interaction between MTMR6 and signaling pathway proteins was analyzed with Genemania database. Then the expression of MTMR6 in human normal liver cell line LO-2 and hepatoma cell lines Huh-7 and HepG2 were measured and compared among the cell lines. Then HepG2 cells was selected as the study object. After MTMR6 gene was knocked down or over-expressed in HepG2 cells

Transwell assay was employed to observe invasion ability

and Western blotting was adopted to detect the expression of MTMR6

PI3K

p-PI3K

AKT

p-AKT

mTOR

p-mTOR MMP-2 and MMP-9.

Results

The expression of MTMR6 was significantly higher in the hepatocellular carcinoma tissues than the paracancer tissues

and it was in a positive linear correlation with PI3K/AKT/mTOR signaling pathway (

0.01)

showing interaction with PI3K

AKT and mTOR. The expression level of MTMR6 was significantly higher in the HepG2 cells than the LO-2 and Huh-7 cells (

0.01). Over-expression of MTMR6 obviously enhanced invasion ability (

0.01)

while its knockdown decreased the ability (

0.01) in HepG2 cells. Knockdown of MTMR6 gene also resulted in decreased phosphorylation of PI3K

AKT and mTOR

and expression levels of MMP-2 and MMP-9 (

0.01)

while over-expression of MTMR6 promoted the phosphorylation of PI3K

AKT and mTOR

and up-regulated the expression of MMP-2 and MMP-9 (

0.01). In addition

LY294002 (a specific PI3K inhibitor) treatment could block the PI3K/AKT/mTOR pathway and down-regulate the expression of MMP-2 and MMP-9 (

0.01)

but had no effect on MTMR6 expression.

Conclusion

MTMR6 may promote the invasion of hepatoma cells through activation of PI3K/AKT/mTOR signaling pathway.

关键词

Keywords

references

SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.

LLOVET J M, KELLEY R K, VILLANUEVA A, et al . Hepatocellular carcinoma[J ] . Nat Rev Dis Primers, 2021, 7(1): 6. DOI: 10.1038/s41572-020-00240-3.

朱玉婉, 解英俊, 张学文. 二氧化硅纳米材料在肝癌治疗中应用进展[J]. 中国实用外科杂志, 2021, 41(6): 710-713, 718. DOI: 10.19538/j.cjps.issn1005-2208.2021.06.17.

ZHU Y W, XIE Y J, ZHANG X W. Progress in the application of silica nano-materials in the treatment of liver cancer[J]. Chin J Pract Surg, 2021, 41(6): 710-713, 718. DOI: 10.19538/j.cjps.issn1005-2208.2021.06.17.

LIU X, HU Y, LI C R, et al . Overexpression of YEATS2 remodels the extracellular matrix to promote hepatocellular carcinoma progression via the PI3K/AKT pathway[J ] . Cancers, 2023, 15(6): 1850. DOI: 10.3390/cancers15061850..

CHOUDHURY P, SRIVASTAVA S, LI Z, et al . Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain[J ] . J Biol Chem, 2006, 281(42): 31762-31769. DOI: 10.1074/jbc.m606344200.

SRIVASTAVA S, CHOUDHURY P, LI Z, et al . Phospha-tidylinositol 3-phosphate indirectly activates KCa 3.1 via 14 amino acids in the carboxy terminus of KCa 3.1 [J ] . Mol Biol Cell, 2006, 17(1): 146-154. DOI: 10.1091/mbc.e05-08-0763..

WANG Y, LEI X, GAO C Y, et al . MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6[J ] . J Biosci, 2019, 44(6): 1-11. DOI: 10.1007/s12038-019-9952-9.

SÁNCHEZ-GARCÍA A, RÍOS-IBARRA C P, RINCÓN-SÁNCHEZ A R, et al . Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid[J ] . Ann Hepatol, 2013, 12(5): 725-732. DOI: 10.1016/S1665-2681(19)31313-4.

WU M, CAI Y L, YANG Y, et al . Vitamin D ameliorates insulin resistance-induced osteopenia by inactivating the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome[J ] . Heliyon, 2023, 9(2): e13215. DOI: 10.1016/j.heliyon.2023.e13215.

LOPEZ J I, CAMENISCH T D, STEVENS M V, et al . CD44 attenuates metastatic invasion during breast cancer progression[J ] . Cancer Res, 2005, 65(15): 6755-6763. DOI: 10.1158/0008-5472.can-05-0863.

LI Y, LIU H, HUANG Y Y, et al . Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of hepa ranase[J ] . Int J Mol Med, 2013, 31(5): 1234-1242. DOI: 10.3892/ijmm.2013.1292.

LI Y W, LI Y, LIU J H, et al . Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer[J ] . Cancer Biol Ther, 2016, 17(3): 272-279. DOI: 10.1080/15384047.2016.1139242.

CREE I A. Cancer biology[M]//Methods in Molecular Biology. Totowa: Humana Press, 2011: 1-11. DOI: 10.1007/978-1-61779-080-5_1.

HANAHAN D, WEINBERG R A. The hallmarks of cancer[J]. Cell, 2000, 100(1): 57-70. DOI: 10.1016/s0092-8674(00)81683-9.

EFFERTH. Molecular principles of cancer invasion and metastasis (Review)[J]. Int J Oncol, 2009, 34(4): 881-895. DOI: 10.3892/ijo_00000214.

SRIVASTAVA S, LI Z, LIN L, et al . The phospha-tidylinositol 3-phosphate phosphatase myotubularin-related protein 6 (MTMR6) is a negative regulator of the Ca 2+ -activated K + channel KCa 3.1 [J ] . Mol Cell Biol, 2005, 25(9): 3630-3638. DOI: 10.1128/MCB.25.9.3630-3638.2005..

JIANG L, LIU J Y, SHI Y, et al . MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling[J ] . J Exp Clin Cancer Res, 2019, 38(1): 1-16. DOI: 10.1186/s13046-019-1186-z..

OPPELT A, HAUGSTEN E, ZECH T, et al . PIKfyve, MTMR3 and their product PtdIns5 P regulate cancer cell migration and invasion through activation of Rac1[J ] . Biochem J, 2014, 461(3): 383-390. DOI: 10.1042/bj20140132..

SCHALETZKY J, DOVE S K, SHORT B, et al . Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases[J ] . Curr Biol, 2003, 13(6): 504-509. DOI: 10.1016/S0960-9822(03)00132-5.

WEN X F. The PI3K AKT pathway in the pathogenesis of prostate cancer[J]. Front Biosci, 2016, 21(5): 1084-1091. DOI: 10.2741/4443.

KHAN K, QUISPE C, JAVED Z, et al . Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer[J ] . Cancer Cell Int, 2020, 20(1): 1-19. DOI: 10.1186/s12935-020-01660-7.

GASPARRI M L, BESHARAT Z M, AHMAD FAROOQI A, et al . MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance[J ] . J Cancer Res Clin Oncol, 2018, 144(12): 2313-2318. DOI: 10.1007/s00432-018-2737-y.

FANG Y K, JI W J, YAN C. Research progress of PI3K/PTEN/AKT signaling pathway associated with renal cell carcinoma[J]. Dis Markers, 2022, 2022: 1-4. DOI: 10.1155/2022/1195875.

LU S M, LIU Y H, TIAN S, et al . KIFC 3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway[J ] . Exp Cell Res, 2023, 426(1): 113564. DOI: 10.1016/j.yexcr.2023.113564..

LI Y H, YIN Y L, HE Y, et al . SOS 1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway[J ] . Biochem Biophys Res Commun, 2022, 637: 161-169. DOI: 10.1016/j.bbrc.2022.11.015..

ZHAO R, GE Y Z, GONG Y J, et al . NAP1L5 targeting combined with MYH9 inhibit HCC progression through PI3K/AKT/mTOR signaling pathway[J ] . Aging, 2022, 14(22): 9000-9019. DOI: 10.18632/aging.204377.

CHANG M. Matrix metalloproteinase profiling and their roles in disease[J]. RSC Adv, 2023, 13(9): 6304-6316. DOI: 10.1039/d2ra07005g.

GIALELI C, THEOCHARIS A D, KARAMANOS N K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting[J]. FEBS J, 2011, 278(1): 16-27. DOI: 10.1111/j.1742-4658.2010.07919.x.

TSAI T C, WU W T, LIN J J, et al . Stellettin B isolated from Stelletta sp. reduces migration and invasion of hepatocellular carcinoma cells through reducing activation of the MAPKs and FAK/PI3K/AKT/mTOR signaling pathways[J ] . Int J Cell Biol, 2022, 2022: 1-9. DOI: 10.1155/2022/4416611..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

circ-gabra5通过miR-455-3p调节AKT蛋白加重阿尔茨海默病的认知损害

索拉非尼联合麦冬皂苷D'共同抑制ERK和AKT通路促进PC3细胞凋亡

下调HOXA-AS2/miR-20a通路促进皮肤鳞癌细胞凋亡并抑制其侵袭迁移

二甲双胍激活AMPK/mTOR通路上调阴茎海绵体自噬增强老年ED大鼠勃起功能

PRR11在结直肠癌中的表达及其对结直肠癌侵袭和转移的影响